Grant: Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Université Laval
$100,000.00
Cellular and molecular mechanisms implicated in the metabolism and actions of endocannabinoids and other arachidonic acid-derived lipid mediators in leukocytes.
FY 2012-13
Summary
Although cannabis has been used in medicine for centuries, nobody clearly understands how it exerts its effects in humans. Cannabis does much more than increasing appetite: it also decreases pain and inflammation. However, our understanding of how cannabis prevents inflammation is very limited. Over the last decade, two lipids that mimic the effects of cannabis were found in the human body. Because of that, they have been termed endocannabinoids. Endocannabinoids contain a lipid named arachidonic acid, which can be transformed into several other lipids that worsen diseases such as arthritis and asthma. Among these lipids are the prostaglandins and the leukotrienes. Our preliminary data indicate that white blood cell behavior is modulated by endocannabinoids. Our current hypothesis is that some endocannabinoids are more involved in the beginning of inflammation while others are involved during the resolution of inflammation. To prove this, we will characterize how and when our white blood cells make endocannabinoids and how the different endocannabinoids promote or block inflammation.
Our long term objective is to develop a therapy promoting the anti-inflammatory effects of endocannabinoids to promote the resolution of inflammation. We believe this can be achieved with a compound that would prevent their transformation into arachidonic acid. This would certainly increase the quality of life of many Canadians suffering from chronic inflammatory diseases such as rheumathoid arthritis
Department
Program
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
285536
Name
Flamand Nicolas
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Cellular and molecular mechanisms implicated in the metabolism and actions of endocannabinoids and other arachidonic acid-derived lipid mediators in leukocytes.
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Infection and Immunity (Bridge Funding)
Keyworddelim
Bioactive Lipid; Cell Biology; Eicosanoid; Endocannbinoid; Inflammation; Lc-Ms/Ms; Lipidomic; Macrophage; Neutrophil
Abstract
Although cannabis has been used in medicine for centuries, nobody clearly understands how it exerts its effects in humans. Cannabis does much more than increasing appetite: it also decreases pain and inflammation. However, our understanding of how cannabis prevents inflammation is very limited. Over the last decade, two lipids that mimic the effects of cannabis were found in the human body. Because of that, they have been termed endocannabinoids. Endocannabinoids contain a lipid named arachidonic acid, which can be transformed into several other lipids that worsen diseases such as arthritis and asthma. Among these lipids are the prostaglandins and the leukotrienes. Our preliminary data indicate that white blood cell behavior is modulated by endocannabinoids. Our current hypothesis is that some endocannabinoids are more involved in the beginning of inflammation while others are involved during the resolution of inflammation. To prove this, we will characterize how and when our white blood cells make endocannabinoids and how the different endocannabinoids promote or block inflammation.
Our long term objective is to develop a therapy promoting the anti-inflammatory effects of endocannabinoids to promote the resolution of inflammation. We believe this can be achieved with a compound that would prevent their transformation into arachidonic acid. This would certainly increase the quality of life of many Canadians suffering from chronic inflammatory diseases such as rheumathoid arthritis
Competitiondate
201303
Approvedterm2
1 yr 0 mth
Pinamesdelim
Flamand, Nicolas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~